Extensively drug-resistant Klebsiella pneumoniae pneumonia: A case report

被引：1

作者：

Karmakar, Saurabh ^{[1
]}

Bhattacharya, Somnath ^{[1
]}

Karmakar, Shilpi ^{[2
]}

Rai, Deependra Kumar ^{[1
]}

机构：

[1] All India Inst Med Sci, Dept Pulm Med, Patna, Bihar, India

[2] King Georges Med Univ, Dept Plast Surg, Lucknow, Uttar Pradesh, India

来源：

JOURNAL OF ACUTE DISEASE | 2020年 / 9卷 / 01期

关键词：

Klebsiella pneumoniae; XDR; Faropenem; Pneumonia;

D O I：

10.4103/2221-6189.276080

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

Rationale: Extensively drug resistant Klebsiella pneumoniae is defined as resistant to least one antimicrobial agent in all but two or lesser antimicrobial categories.Patient concerns: A 58-year-old diabetic male was admitted with bilateral pneumonia. Sputum culture grew Klebsiella pneumoniae which was sensitive to only colistin on culture. Diagnosis: Acute hypoxemic respiratory failure causes bilateral pneumonia (community acquired).Intervention: The combination therapy of oral faropenem and intravenous colistin for treatment.Outcome: The patient recovered fully and is doing well on follow-up.Lesson: Emerging antibiotic-resistant and hypervirulent strains of Klebsiella pneumoniae should drive further studies on novel antibiotic combinations for extensively drug-resistant Klebsiella pneumonia.

引用

页码：40 / 42

页数：3

共 50 条

[21] Clinical experience with ceftazidime/avibactam for the treatment of extensively drug-resistant or pandrug-resistant Klebsiella pneumoniae in neonates and children
Gundeslioglu, Ozlem Ozgur
Haytoglu, Zeliha
Gumus, Hatice Hale
Ekinci, Faruk
Kibar, Filiz
Cay, Ummuhan
Alabaz, Derya
Ozlu, Ferda
Horoz, Ozden Ozgur
Yildizdas, Riza Dincer
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2024, 43 (12) : 2361 - 2369
[22] Pneumonia Due to Drug-Resistant Streptococcus pneumoniae
Jinno, Sadao
Jacobs, Michael R.
CURRENT INFECTIOUS DISEASE REPORTS, 2012, 14 (03) : 292 - 299
[23] Pneumonia Due to Drug-Resistant Streptococcus pneumoniae
Sadao Jinno
Michael R. Jacobs
Current Infectious Disease Reports, 2012, 14 : 292 - 299
[24] Use of Ceftazidime-avibactam for the Treatment of Extensively drug-resistant or Pan drug-resistant Klebsiella pneumoniae in Neonates and Children <5 Years of Age
Iosifidis, Elias
Chorafa, Elisavet
Agakidou, Eleni
Kontou, Aggeliki
Violaki, Asimina
Volakli, Eleni
Christou, Eleni-Ifigeneia
Zarras, Charalampos
Drossou-Agakidou, Vassiliki
Sdougka, Maria
Roilides, Emmanuel
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2019, 38 (08) : 812 - 815
[25] Extensively drug-resistant typhoid fever; it's not that simple: a case report
Rahim, Fawad
Amin, Said
Noor, Mohammad
Naeem, Malghalara
Bangash, Ayesha
JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2023, 73 (06) : 1320 - 1322
[26] Extensively drug-resistant Acinetobacter baumannii lung abscess and empyema in a patient with fulminant mycoplasma pneumoniae pneumonia
Yang, Siyu
Wei, Chaojie
RESPIRATORY MEDICINE CASE REPORTS, 2025, 53
[27] Ceftazidime-Avibactam for Hospital Acquired Pneumonia Due to Extended Drug-Resistant Klebsiella pneumoniae
Rup, Amit Ranjan
Dash, Arun Kumar
Patnaik, Sibabratta
INDIAN JOURNAL OF PEDIATRICS, 2021, 88 (03): : 290 - 291
[28] Ceftazidime-Avibactam for Hospital Acquired Pneumonia Due to Extended Drug-Resistant Klebsiella pneumoniae
Amit Ranjan Rup
Arun Kumar Dash
Sibabratta Patnaik
The Indian Journal of Pediatrics, 2021, 88 : 290 - 291
[29] Molecular Nanomachines Disrupt Bacterial Cell Wall, Increasing Sensitivity of Extensively Drug-Resistant Klebsiella pneumoniae to Meropenem
Galbadage, Thushara
Liu, Dongdong
Alemany, Lawrence B.
Pal, Robert
Tour, James M.
Gunasekera, Richard S.
Cirillo, Jeffrey D.
ACS NANO, 2019, 13 (12) : 14377 - 14387
[30] Evaluating the genome and resistome of extensively drug-resistant Klebsiella pneumoniae using native DNA and RNA Nanopore sequencing
Pitt, Miranda E.
Nguyen, Son H.
Duarte, Tania P. S.
Teng, Haotian
Blaskovich, Mark A. T.
Cooper, Matthew A.
Coin, Lachlan J. M.
GIGASCIENCE, 2020, 9 (02):

← 1 2 3 4 5 →